All updated as on -
In 2023, the global perfusion system market was valued at $1,199,000,000. By 2031, it is expected to reach $1,690,000,000, a growth rate of 5.9% from $1,244,79,000,000 in 2024 to $1,690,53,000,000 in 2031.
Research in the fields of medicine and biology relies heavily on perfusion systems, especially in the areas of organ transplantation and cellular metabolism. Outside of the body, perfusion structures allow the controlled movement of fluids rich in nutrients and oxygen across biological tissues or organs. Laboratory tests and ensuring that organs remain viable during delivery both rely on this generation.
The rising need for organ transplantation is a key factor propelling the perfusion machine industry. Due to their ability to preserve and verify donor organs, perfusion structures have gained popularity, ultimately enhancing the success rates of transplant strategies, in light of the ongoing global scarcity of transplantable organs. Modern advancements in perfusion, such as normothermic perfusion, have also made it possible to evaluate organ viability more accurately and to prolong maintenance periods.
Perfusion systems play a crucial role in cell and tissue culture in pharmaceutical and biotechnological research, enabling investigators to better understand disease causes and develop more effective treatment strategies. Perfusion systems have increased their programs in drug research and regenerative medicine due to their ability to mimic physiological settings in vitro with fine control over nutrition delivery and waste removal. Modern healthcare and research organizations are investing in better organ maintenance, more clinical investigations, and better therapeutic features and surgical outcomes for transplants, therefore the perfusion device industry is likely to keep growing.
System performance, scalability, and automation have all been greatly enhanced by technical improvements in the perfusion systems sector. Cell and tissue cultures are now more accurate and efficient because to the incorporation of modern sensors and control systems, which have improved process monitoring and control. Risks including multiple organ failure and other chronic illnesses have increased the demand for perfusion systems, which is driven by an increasingly elderly population. The need for perfusion systems has skyrocketed due to increased awareness of chronic illnesses, the success of organ transplants, and better access to healthcare. Thus, the need for improved cardiovascular disease diagnosis and treatment, organ donations, and technological breakthroughs in perfusion technologies are driving significant development and innovation in the perfusion systems business.
The perfusion systems industry's income took a hit in the first half of 2020 because to the recent COVID-19 outbreak. Several worldwide businesses, notably those involved in healthcare, were negatively affected by the coronavirus outbreak, which increased the disease burden during the pandemic phase. A major blow to the expansion of the perfusion systems industry was dealt by these factors. A considerable drop in patient visits for the diagnosis and treatment of perfusion systems and related chronic disorders was seen at various healthcare facilities throughout the world. A number of nations' medical services, such as organ donation and other surgical operations, have been postponed due to the COVID-19 pandemic's impact on fewer people visiting healthcare facilities. The development, delivery, and distribution of perfusion systems have all been delayed as a result of the pandemic's disruption of global supply networks.
There was a lot of buzz about normothermic perfusion, the practice of keeping donor organs at normal temperature as they are transported. Increases in the frequency of fruitful organ transplants may be possible as a result of improved assessment of organ viability and longer protective periods. Advanced Monitoring Integration: The importance of perfusion systems that incorporate high-quality tracking and diagnostic instruments grew. The evaluation of organ health and capacity was advanced by the ability to gather and analyze data in real-time.
The most recent perfusion system technologies are attractive to healthcare professionals in North America because to technological developments such as better control systems, enhanced biocompatibility, and improved monitoring capabilities. A major factor propelling the demand for perfusion systems is the reimbursement situation in the region. Hospitals and other healthcare facilities are able to employ perfusion systems because of government healthcare programs, favorable payment procedures, and insurance coverage. A number of factors are contributing to the growing demand for perfusion systems in the North American market. These include a well-developed healthcare infrastructure, a high rate of cardiovascular diseases, new technologies, supportive reimbursement policies, an emphasis on minimally invasive surgeries, and ongoing research and clinical trials.
Report Coverage
Global Perfusion System research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Perfusion System report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Perfusion System competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Perfusion System market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Perfusion System market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Perfusion System market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Getinge AB, Medtronic plc, Terumo Corporation, LivaNova PLC, XENIOS AG (Fresenius Kabi), Spectrum Laboratories, Inc., XVIVO Perfusion AB, Organ Assist B.V., Harvard Apparatus (Harvard Bioscience, Inc.), Biometrix BV, Transonic Systems, Inc., Alung Technologies, Inc., LEONI AG, Repligen Corporation, Belmont Instrument Corporation, Sorin Group (Now LivaNova PLC), HEMO2life, NIPRO Corporation, Alliance Medical Products, GlobalMed, Inc.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Perfusion System market based on the below-mentioned segments:
Global Perfusion System Market, By Component
Oxygenators
Heart-Lung Machine
Perfusion Pumps
Monitoring System
Bioreactor Perfusion System
Others
Global Perfusion System market, By Application
Cardiopulmonary Perfusion System
Cell Perfusion System
Ex-Vivo Organ Perfusion System
Global Perfusion System Market, By End User
Hospitals
Ambulatory Surgical Centers
Others
Global Perfusion System market, Regional Analysis
Research in the fields of medicine and biology relies heavily on perfusion systems, especially in the areas of organ transplantation and cellular metabolism. Outside of the body, perfusion structures allow the controlled movement of fluids rich in nutrients and oxygen across biological tissues or organs. Laboratory tests and ensuring that organs remain viable during delivery both rely on this generation.
The rising need for organ transplantation is a key factor propelling the perfusion machine industry. Due to their ability to preserve and verify donor organs, perfusion structures have gained popularity, ultimately enhancing the success rates of transplant strategies, in light of the ongoing global scarcity of transplantable organs. Modern advancements in perfusion, such as normothermic perfusion, have also made it possible to evaluate organ viability more accurately and to prolong maintenance periods.
Perfusion systems play a crucial role in cell and tissue culture in pharmaceutical and biotechnological research, enabling investigators to better understand disease causes and develop more effective treatment strategies. Perfusion systems have increased their programs in drug research and regenerative medicine due to their ability to mimic physiological settings in vitro with fine control over nutrition delivery and waste removal. Modern healthcare and research organizations are investing in better organ maintenance, more clinical investigations, and better therapeutic features and surgical outcomes for transplants, therefore the perfusion device industry is likely to keep growing.
System performance, scalability, and automation have all been greatly enhanced by technical improvements in the perfusion systems sector. Cell and tissue cultures are now more accurate and efficient because to the incorporation of modern sensors and control systems, which have improved process monitoring and control. Risks including multiple organ failure and other chronic illnesses have increased the demand for perfusion systems, which is driven by an increasingly elderly population. The need for perfusion systems has skyrocketed due to increased awareness of chronic illnesses, the success of organ transplants, and better access to healthcare. Thus, the need for improved cardiovascular disease diagnosis and treatment, organ donations, and technological breakthroughs in perfusion technologies are driving significant development and innovation in the perfusion systems business.
The perfusion systems industry's income took a hit in the first half of 2020 because to the recent COVID-19 outbreak. Several worldwide businesses, notably those involved in healthcare, were negatively affected by the coronavirus outbreak, which increased the disease burden during the pandemic phase. A major blow to the expansion of the perfusion systems industry was dealt by these factors. A considerable drop in patient visits for the diagnosis and treatment of perfusion systems and related chronic disorders was seen at various healthcare facilities throughout the world. A number of nations' medical services, such as organ donation and other surgical operations, have been postponed due to the COVID-19 pandemic's impact on fewer people visiting healthcare facilities. The development, delivery, and distribution of perfusion systems have all been delayed as a result of the pandemic's disruption of global supply networks.
There was a lot of buzz about normothermic perfusion, the practice of keeping donor organs at normal temperature as they are transported. Increases in the frequency of fruitful organ transplants may be possible as a result of improved assessment of organ viability and longer protective periods. Advanced Monitoring Integration: The importance of perfusion systems that incorporate high-quality tracking and diagnostic instruments grew. The evaluation of organ health and capacity was advanced by the ability to gather and analyze data in real-time.
The most recent perfusion system technologies are attractive to healthcare professionals in North America because to technological developments such as better control systems, enhanced biocompatibility, and improved monitoring capabilities. A major factor propelling the demand for perfusion systems is the reimbursement situation in the region. Hospitals and other healthcare facilities are able to employ perfusion systems because of government healthcare programs, favorable payment procedures, and insurance coverage. A number of factors are contributing to the growing demand for perfusion systems in the North American market. These include a well-developed healthcare infrastructure, a high rate of cardiovascular diseases, new technologies, supportive reimbursement policies, an emphasis on minimally invasive surgeries, and ongoing research and clinical trials.
Report Coverage
Global Perfusion System research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Perfusion System report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Perfusion System competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Perfusion System market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Getinge AB, Medtronic plc, Terumo Corporation, LivaNova PLC, XENIOS AG (Fresenius Kabi), Spectrum Laboratories, Inc., XVIVO Perfusion AB, Organ Assist B.V., Harvard Apparatus (Harvard Bioscience, Inc.), Biometrix BV, Transonic Systems, Inc., Alung Technologies, Inc., LEONI AG, Repligen Corporation, Belmont Instrument Corporation, Sorin Group (Now LivaNova PLC), HEMO2life, NIPRO Corporation, Alliance Medical Products, GlobalMed, Inc. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Perfusion System Market from 2021 to 2031.
- Market Forecast for Perfusion System Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Perfusion System competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Perfusion System
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Perfusion System market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Perfusion System market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Getinge AB, Medtronic plc, Terumo Corporation, LivaNova PLC, XENIOS AG (Fresenius Kabi), Spectrum Laboratories, Inc., XVIVO Perfusion AB, Organ Assist B.V., Harvard Apparatus (Harvard Bioscience, Inc.), Biometrix BV, Transonic Systems, Inc., Alung Technologies, Inc., LEONI AG, Repligen Corporation, Belmont Instrument Corporation, Sorin Group (Now LivaNova PLC), HEMO2life, NIPRO Corporation, Alliance Medical Products, GlobalMed, Inc.
Primary Target Market
- Market Players of Perfusion System
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Perfusion System market based on the below-mentioned segments:
Global Perfusion System Market, By Component
Oxygenators
Heart-Lung Machine
Perfusion Pumps
Monitoring System
Bioreactor Perfusion System
Others
Global Perfusion System market, By Application
Cardiopulmonary Perfusion System
Cell Perfusion System
Ex-Vivo Organ Perfusion System
Global Perfusion System Market, By End User
Hospitals
Ambulatory Surgical Centers
Others
Global Perfusion System market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive perfusion system market market research and competitor analysis for your business to help you develop more profound insights into the perfusion system market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the perfusion system market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.